Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01

Fujitani, Kazumasa; Yang, Han-Kwang; Kurokawa, Yukinori; Park, Do Joong; Tsujinaka, Toshimasa; Park, Byung-Joo; Fukuda, Haruhiko; Noh, Sung Hoon; Boku, Narikazu; Bang, Yung-Jue; Sasako, Mitsuru; Lee, Jong-Inn

doi:10.1093/jjco/hyn058

서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

S-Space

Publications

Detailed Information

Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01

Cited 54 time in Web of Science Cited 59 time in Scopus

Export

Authors: Fujitani, Kazumasa; Yang, Han-Kwang; Kurokawa, Yukinori; Park, Do Joong; Tsujinaka, Toshimasa; Park, Byung-Joo; Fukuda, Haruhiko; Noh, Sung Hoon; Boku, Narikazu; Bang, Yung-Jue; Sasako, Mitsuru; Lee, Jong-Inn

Issue Date: 2008-07

Publisher: Oxford University Press

Citation: Japanese Journal of Clinical Oncology, Vol.38 No.7, pp.504-506

Abstract: A randomized controlled trial has started in both Japan and Korea to evaluate the role of gastrectomy in the management of incurable advanced gastric cancer (AGC). Patients with AGC diagnosed as having a single non-curable factor are randomized to gastrectomy plus chemotherapy or chemotherapy alone. Surgeons at 33 specialized centers in Japan and at 15 high-volume hospitals in Korea will recruit 330 patients. Primary end-point is overall survival, and secondary end-points are progression-free survival and adverse events associated with either gastrectomy or chemotherapy.